HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Lifileucel approval the start of a ‘glorious future’ for cell therapy in solid tumors Josh Friedman
• AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research Matthew Shinkle
• AI approach predicts glomerular filtration rate after nephrectomy Mark Leiser
• Blenrep regimen extends PFS in advanced multiple myeloma Mark Leiser
• Brentuximab vedotin regimen extends survival in advanced DLBCL Matthew Shinkle
• Cancer test results shared to portals often viewed by patients before ordering clinicians Jennifer Byrne; Sheena Bhalla, MD
• Consensus recommendations aim to prevent breast cancer-related lymphedema Jennifer Byrne
• Cost of cancer care discussions ‘very rare’ between physicians, patients Jennifer Byrne
• Development of T-cell lymphoma ‘very serious’ but ‘very rare’ after CAR T-cell therapy Josh Friedman
• Guideline-directed care may reduce sickle cell-related cerebrovascular disease Mark Leiser
• Guidelines: Toxicity management vital with tumor-infiltrating lymphocytes Josh Friedman
• Hollywood gets bad review for creating ‘anxiety and fear’ through its portrayal of cancer Josh Friedman
• Ibrutinib plus venetoclax represents ‘new standard therapy’ for advanced mantle cell lymphoma Jennifer R. Southall
• Mobile app helps address sexual dysfunction in stem cell transplant survivors Matthew Shinkle
• ‘Molecular jackhammers’ show potential to kill cancer cells within minutes Jennifer Byrne
• Pembrolizumab regimen confers ‘durable and robust’ benefit in triple-negative breast cancer Mark Leiser
• Prostate cancer survivors report improved sexual function, vitality on plant-based diets Josh Friedman
• Psilocybin hailed as ‘potential breakthrough’ for depression among patients with cancer Josh Friedman
• Ruxolitinib cream ‘effective’ in reducing rashes, lesions caused by cutaneous GVHD Josh Friedman
• Screening for health-related social needs should be 'integral' part of cancer care Jennifer Byrne
• Study of prior authorization’s impact on cancer treatment reveals ‘signal of danger’ Jennifer Byrne; Bridgette Thom, PhD
• Study provides ‘increased confidence’ about using taxanes for breast cancer in pregnancy Jennifer R. Southall
• Tumor-related bacteria may provide clues into early-onset colorectal cancer Jennifer Byrne; Shimoli V. Barot, MD
• Vaccine for triple-negative breast cancer produces ‘exciting’ results in early testing Josh Friedman; Justin M. Johnson, PhD
• Virtual mind-body program cuts need for emergency care among patients with cancer Jennifer R. Southall